Pricing Log in Create free account

Ginkgo Bioworks Holdings, Inc. (DNA) vs Inventiva S.A. Sponsored ADR (IVA)

Ginkgo Bioworks Holdings, Inc. and Inventiva S.A. Sponsored ADR are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Inventiva S.A. Sponsored ADR are of similar size ($791.9M and $740.0M). Inventiva S.A. Sponsored ADR grew revenue faster over the last twelve months: 547.9% against −37.0%. Ginkgo Bioworks Holdings, Inc. has the higher net margin (−219.6% vs −750.3%) and the lower return on invested capital (−161.9% vs 0.00%). Across the 18 metrics below, Ginkgo Bioworks Holdings, Inc. leads on 10 and Inventiva S.A. Sponsored ADR on 8.

Valuation

Metric DNA IVA Biotechnology median
P/E n/m n/m 8.50
P/S 4.82 5.79 9.71
P/B 1.52 1.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.01 0.64
EV/Sales 2.99 (0.10) 9.21
Earnings yield (48.78%) (121.19%) (33.15%)
Free cash flow yield (27.32%) (120.95%) (25.50%)

Profitability

Metric DNA IVA Biotechnology median
Gross margin 68.04% 0.00% 65.16%
Operating margin (231.13%) 0.00% 0.00%
Net margin (219.60%) (750.28%) 0.00%
Free cash flow margin (131.57%) 0.00% 0.00%
Return on equity (56.29%) 0.00% (56.36%)
Return on assets (26.19%) 0.00% (48.04%)
Return on invested capital (161.94%) 0.00% 0.00%

Growth

Metric DNA IVA Biotechnology median
Revenue growth (TTM) (37.02%) 547.89% 6.02%
EPS growth (last fiscal year) 46.49% 35.44% 30.26%
Revenue growth, 5-year CAGR 17.29% 8.33% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNA IVA Biotechnology median
Debt to equity 0.00 1.13 0.00
Current ratio 4.57 3.81 4.72
Net debt to EBITDA 1.63 0.29 0.96

Dividend

Metric DNA IVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DNA IVA Biotechnology median
Market cap 791.92m 739.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack